Tower Research Capital LLC (Trc) Mirati Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $37,581 - $55,830	895 Added 59.99%	2,387 $140,000
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $369,128 - $602,157	-13,278 Reduced 89.9%	1,492 $64,000
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $389,517 - $533,551	10,781 Added 270.27%	14,770 $533,000
Q1 2023 May 09, 2023	SELL	$36.54 - $54.26 $281,102 - $417,422	-7,693 Reduced 65.85%	3,989 $148,000
Q4 2022 Feb 10, 2023	BUY	$41.27 - $98.62 $231,400 - $552,962	5,607 Added 92.3%	11,682 $529,000
Q3 2022 Nov 10, 2022	SELL	$59.5 - $86.7 $518,899 - $756,110	-8,721 Reduced 58.94%	6,075 $424,000
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $228,929 - $518,598	5,846 Added 65.32%	14,796 $994,000
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $527,252 - $1.05 Million	6,954 Added 348.4%	8,950 $736,000
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $99,799 - $143,859	756 Added 60.97%	1,996 $293,000
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $387,801 - $520,815	-2,935 Reduced 70.3%	1,240 $219,000
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $267,984 - $334,477	1,861 Added 80.42%	4,175 $675,000
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $116,965 - $163,104	-736 Reduced 24.13%	2,314 $396,000
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $46,994 - $69,678	-290 Reduced 8.68%	3,050 $670,000
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $108,389 - $160,077	957 Added 40.16%	3,340 $554,000
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $169,799 - $283,879	2,358 Added 9432.0%	2,383 $272,000
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $42,914 - $71,469	-615 Reduced 96.09%	25 $2,000
Q4 2019 Feb 07, 2020	SELL	$70.76 - $128.86 $56,466 - $102,830	-798 Reduced 55.49%	640 $82,000
Q3 2019 Nov 05, 2019	BUY	$77.91 - $109.6 $112,034 - $157,604	1,438 New	1,438 $112,000
Q2 2019 Aug 13, 2019	SELL	$59.49 - $104.71 $69,484 - $122,301	-1,168 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $50,895 - $92,055	1,166 Added 58300.0%	1,168 $86,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $14,656 - $21,722	-458 Reduced 99.57%	2 $0
Q3 2018 Nov 13, 2018	BUY	$47.1 - $62.7 $21,666 - $28,842	460 New	460 $22,000
Q2 2018 Aug 15, 2018	SELL	$26.05 - $52.4 $59,003 - $118,686	-2,265 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $11,919 - $24,220	693 Added 44.08%	2,265 $70,000
Q4 2017 Feb 09, 2018	BUY	$12.65 - $19.0 $19,885 - $29,868	1,572	1,572 $28,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account